Results 221 to 230 of about 63,359 (335)
Expressão de CXCR7 e CXCR4 em em astrocitomas iniltrativos em relação ao tecido cerebral não neoplásico e sua interação com HIF1alfa e IDH1 [PDF]
André de Macedo Bianco
openalex +1 more source
ABSTRACT Background Anticancer chemotherapy is an underappreciated contributor to cancer cachexia, an often‐irreversible body‐wasting condition that causes 20%–30% of cancer‐related deaths. An obstacle to predicting, monitoring and understanding the mechanisms underlying chemotherapy cachexia is that each cancer (and subtype) is assigned different ...
Dean G. Campelj+9 more
wiley +1 more source
METABOLIC IMAGING BIOMARKERS FOR MUTANT IDH1 GLIOMAS [PDF]
Sabrina M. Ronen+5 more
openalex +1 more source
Background Edited MRS technique such as MEshcher‐GArwood Point RESolved Spectroscopy (MEGA‐PRESS) can determine isocitrate dehydrogenase mutation (IDH) mutation status in patients with gliomas but its accuracy in assessing glioma grade has not yet been formally evaluated.
Maria L. Brun‐Vergara+10 more
wiley +1 more source
Can Diffusion Tensor Imaging Noninvasively Detect IDH1 Gene Mutations in Astrogliomas? A Retrospective Study of 112 Cases [PDF]
Wenli Tan+5 more
openalex +1 more source
ABSTRACT Background Biliary tract cancers (BTCs) represent distinct biological and genomic entities. Anatomic and geographic heterogeneity in genomic profiling of BTC subtypes, genomic co‐alterations, and their impact on long‐term outcomes are not well defined.
Diamantis I. Tsilimigras+3 more
wiley +1 more source
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Masato Sasaki+21 more
openalex +2 more sources
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity [PDF]
Suganthi Chittaranjan+15 more
openalex +1 more source
ABSTRACT The clinical utility of comprehensive genomic profiling (CGP) in intrahepatic cholangiocarcinoma (ICC) remains to be fully elucidated. This study analysed CGP test results and evaluated treatment outcomes with fibroblast growth factor receptor (FGFR) inhibitors in patients with ICC, aiming to assess their efficacy in cases with specific FGFR ...
Makiko Urabe+10 more
wiley +1 more source